Corporate Overview

SQZ Biotechnologies is a clinical-stage biotechnology company focused on unlocking the full potential of cell therapies. The company’s proprietary Cell Squeeze® technology offers the unique ability to deliver multiple biological materials into many patient cell types to engineer what we believe can be a broad range of potential therapeutics. Our goal is to create well-tolerated cell therapies that can provide therapeutic benefit for patients and improve the patient experience over existing cell therapy approaches. With accelerated production timelines under 24 hours and the opportunity to eliminate preconditioning and lengthy hospital stays, our approach could change the way people think about cell therapies.

By the Numbers


Times more efficient CD8 T cell activation with our SQZ APC platform over traditional vaccine approaches


Hours or less to manufacture all patient doses for our current cell therapies


Cells engineered in under a minute


Core Cell Squeeze® technology, Unlimited possibilities

Latest News

View all news

Latest Events

View All Events